Alkyllithium SN′ Cyclizations
Spirocycle 41. Acetal 38 (40.0 mg, 0.087 mmol) was dissolved
in 0.87 mL of 1:1 THF/hexanes. To this solution was added 0.1
mg of 1,10-phenanthroline, then the solution was cooled to -78
°C and titrated with n-BuLi (1.6 M in hexanes) to a brown-red
endpoint to remove any trace of water. A solution of LiDBB (0.87
mL, 0.35 mmol), precooled to -78 °C, was introduced into the
reaction vessel, and the resulting dark green mixture was allowed
to stir at -78 °C for 12 h. The excess LiDBB was then quenched
with 2 mL of MeOH, and the mixture was diluted with 5 mL of
water. The aqueous phase was extracted with pentane (2 × 10 mL),
then combined organic layers were dried over anhydrous MgSO4,
filtered, and concentrated under reduced pressure. The resulting
residue was purified by silica gel chromatography (20% Et2O/
pentane) to give 26.0 mg of the cyclized product 41 (>98:2 E/Z,
74% yield) as a slightly yellow oil: Rf 0.50 (10% Et2O/pentane);
to the formation of a spiro ring with a single configuration at
the spiro center and the adjacent allylic center. These experi-
ments will be useful for predicting the stereochemical outcome
of more complex alkyllithium cyclizations.
Experimental Section23
Mismatched Cyclization Precursor 39. To a 0 °C solution of
diisopropylamine (0.0920 mL, 0.655 mmol) in THF (2.18 mL) was
added n-butyllithium (1.6 M in hexanes, 0.405 mL, 0.648 mmol)
dropwise over a 5 min period. The solution was stirred at 0 °C for
0.5 h and then cooled to -78 °C. A solution of acetals 36 and 37
(0.150 g, 0.649 mmol) in 1 mL of THF was added to the reaction
mixture, and the resulting yellow solution was allowed to stir for
1 h at -78 °C. A solution of (R)-(9-iodo-4-methoxynon-5-enyl)-
benzene (26) (0.116 g, 0.324 mmol) in THF (1.00 mL) was
introduced into the reaction vessel and stirring was continued at
-78 °C for 15 h. The excess anion was quenched with a saturated
aqueous solution of NH4Cl (1 mL), the mixture was washed with
water (5 mL), and the aqueous layer was extracted with pentane (3
× 10 mL). The combined organic layers were washed with saturated
NaHCO3(aq) (2 × 5 mL) and brine (2 × 10 mL), dried over
anhydrous MgSO4, filtered, and concentrated under reduced pres-
sure. The resulting oil was purified by silica gel chromatography
(20% Et2O/pentane) to give 0.138 g (92% yield) of the desired
compound as a colorless oil: Rf 0.56 (20% Et2O/pentane); [R]D
+43 (c 0.48, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.28 (m, 4H),
7.18 (m, 6H), 5.58 (dt, 1H, J ) 15.2, 6.6 Hz), 5.29 (dd, 1H, J )
15.4, 8.1 Hz), 5.07 (q, 1H, J ) 5.1 Hz), 3.89 (m, 1H), 3.48 (m,
1H), 3.23 (s, 3H), 2.82 (ddd, 1H, J ) 14.1, 10.0, 5.4 Hz), 2.67 (m,
1H), 2.62 (t, 2H, J ) 7.1 Hz), 2.12 (m, 2H), 1.92-1.60 (m, 10H),
1.54-1.48 (m, 2H), 1.38 (d, 3H, J ) 5.1 Hz) ppm; 13C NMR (125
MHz, CDCl3) δ 142.5, 141.3, 132.7, 131.6, 128.5, 128.4, 128.3,
128.2, 126.0, 125.7, 119.0, 96.5, 82.3, 74.1, 72.8, 55.9, 40.0, 39.3,
37.0, 35.9, 35.2, 31.7, 31.0, 27.3, 22.8, 20.7 ppm; IR (neat) 2930,
1603, 1495, 1453, 1333, 1140 cm-1; HRMS (CI/ammonia) m/z
calcd for C30H40NO3 [M ]+ 461.2930, found 461.2916.
Matched Cyclization Precursor 38. Synthesis of acetal 38 was
accomplished by following the same experimental protocol that was
used for the preparation of acetal 39. The diastereomeric mixture
comprised of acetals 31 and 32 (0.278 g, 1.20 mmol) was alkylated
with alkyl iodide 26 (0.216 g, 0.602 mmol), which gave the desired
matched cyclization precursor 38 in 84% yield: Rf 0.56 (20% Et2O/
pentane); [R]D -30 (c 0.5, CHCl3); 1H NMR (500 MHz, CDCl3) δ
7.28 (m, 4H), 7.18 (m, 6H), 5.58 (dt, 1H, J ) 15.3, 6.6 Hz), 5.29
(dd, 1H, J ) 15.5, 8.1 Hz), 5.07 (q, 1H, J ) 4.8 Hz), 3.88 (m,
1H), 3.47 (m, 1H), 3.23 (s, 3H), 2.81 (ddd, 1H, J ) 14.2, 10.2, 5.5
Hz), 2.68 (m, 1H), 2.61 (t, 2H, J ) 7.1 Hz), 2.12 (m, 2H), 1.91-
1.60 (m, 10H), 1.54-1.48 (m, 2H), 1.38 (d, 3H, J ) 5.0 Hz) ppm;
13C NMR (125 MHz, CDCl3) δ 142.5, 141.3, 132.7, 131.6, 128.5,
128.4, 128.3, 128.2, 126.0, 125.7, 119.0, 96.5, 82.3, 74.1, 72.8,
55.9, 39.9, 39.3, 37.0, 35.9, 35.2, 31.7, 31.1, 27.4, 22.8, 20.7 ppm;
IR (neat) 2928, 1603, 1496, 1454, 1378, 1143 cm-1; HRMS (CI/
ammonia) m/z calcd for C30H40NO3 [M ]+ 461.2930, found
461.2919.
1
[R]D -79 (c 0.96, CHCl3); H NMR (500 MHz, CDCl3) δ 7.31
(m, 4H), 7.20 (m, 6H), 5.51 (dd, 1H, J ) 15.3, 9.3 Hz), 5.41 (dt,
1H, J ) 15.2, 6.6 Hz), 4.82 (q, 1H, J ) 5.0 Hz), 3.77 (m, 1H),
2.80 (ddd, 1H, J ) 14.1, 9.8, 5.6 Hz), 2.72 (m, 2H), 2.62 (t, 2H,
J ) 7.6), 2.06 (q, 2H, J ) 6.9 Hz), 1.99-1.83 (m, 3H), 1.75-1.63
(m, 4H), 1.62-1.48 (m, 3H), 1.46 (m, 2H), 1.26 (d, 3H, J ) 5.1
Hz) ppm; 13C NMR (125 MHz, CDCl3) δ 142.5, 142.0, 131.6,
129.8, 128.5, 128.4, 128.3, 128.2, 125.8, 125.7, 94.8, 83.3, 72.4,
46.5, 40.7, 39.5, 37.6, 35.4, 32.1, 31.4 (2C), 31.3, 21.3, 19.2 ppm;
IR (neat) 2936, 1604, 1496, 1454, 1328, 1135 cm-1; HRMS (CI/
ammonia) m/z calcd for C28H36O2 [M]+ 404.2715, found 404.2718.
Spirocycle 45. Acetal 39 (30.0 mg, 0.065 mmol) was cyclized
by using the same experimental protocol that was developed for
the cyclization of acetal 38. Cyclic acetals 44 and 45 were isolated
as an inseparable mixture of geometric isomers (15:85 E/Z,
respectively) (18.0 mg, 72% overall yield) as a slightly yellow oil:
Major isomer 45: Rf 0.50 (10% Et2O/pentane); 1H NMR (500 MHz,
CDCl3) δ 7.29 (m, 4H), 7.19 (m, 6H), 5.53 (app. t, 1H, J ) 10.8
Hz), 5.35 (dt, 1H, J ) 10.3, 6.8 Hz), 4.64 (q, 1H, J ) 5.1), 3.65
(m, 1H), 2.91 (m, 1H), 2.78 (ddd, 1H, J ) 13.8, 9.7, 5.6 Hz), 2.68
(ddd, 1H, J ) 13.8, 9.3, 6.8 Hz), 2.62 (ddd, 2H, J ) 7.5, 7.5, 3.2
Hz), 2.10-1.95 (m, 3H), 1.88 (m, 2H), 1.74-1.61 (m, 6H), 1.50
(m, 3H), 1.25 (d, 3H, J ) 5.1 Hz) ppm; 13C NMR (125 MHz,
CDCl3) δ 142.4, 142.0, 131.4, 128.5, 128.4, 128.3, 128.2, 128.0,
125.8, 125.7, 95.2, 83.6, 72.4, 41.0, 40.9, 40.0, 37.6, 35.5, 32.1,
31.4, 31.3, 26.9, 21.3, 19.8 ppm; IR (neat) 2936, 1603, 1496, 1454,
1330, 1134 cm-1; HRMS (ESI) calcd for C28H36O2Na [M + Na]+
427.2613, found 427.2618.
Acknowledgment. The National Institutes of Health
(GM65388) provided support for this project. Novartis Phar-
maceuticals is gratefully acknowledged for fellowship support
to T.E.L.
Supporting Information Available: Experimental details for
the preparation of the cyclization substrates and the characterization
and correlation of the products as well as proton and 13C NMR
spectra. This material is available free of charge via the Internet at
(23) The general experimental information may be found in the Sup-
porting Information.
JO052166U
J. Org. Chem, Vol. 71, No. 3, 2006 1073